Digoxin-Specific Antibody Fragment Dosing: A Case Series.

Area of Science:

• Toxicology
• Pharmacology
• Clinical Medicine

Background:

• Digoxin-specific antibody fragments (DSFab) are crucial for treating cardiac glycoside poisoning.
• Current DSFab dosing relies on steady-state serum concentrations, historical data, or empiric regimens.
• Empiric dosing often suggests 3-6 vials for chronic and 10-20 vials for acute digoxin poisoning.

Purpose of the Study:

• To determine average DSFab dosing requirements based on serum concentrations or historical data.
• To compare actual DSFab requirements with established empiric dosing regimens.
• To evaluate potential overestimation in current digoxin poisoning treatment protocols.

Main Methods:

• Retrospective analysis of 11-year data from the Illinois Poison Center.
• Inclusion of 140 chronic and 26 acute digoxin poisoning cases requiring DSFab.
• Calculation of average recommended DSFab doses from case data.

Main Results:

• Average DSFab dose for chronic digoxin poisoning was 3.05 vials (SD ± 1.31).
• Average DSFab dose for acute digoxin poisoning was 6.33 vials (SD ± 5.26).
• These findings indicate actual needs are often lower than empiric recommendations.

Conclusions:

• Empiric dosing regimens for DSFab in digoxin poisoning may frequently overestimate the required amount.
• Revised dosing guidelines could optimize DSFab utilization and potentially reduce healthcare costs.
• Further research into refined dosing strategies for digoxin toxicity is warranted.